How To Fund Your MedTech: Non-Dilutive Funding Options.

We've assembled a stellar lineup of experts to discuss the funding landscape in Healthtech & Medical Devices.
Learn how your value proposition determines the optimal timing and strategies for maximising your chances of success.

What You Will Learn:

How to build a staged funding strategy and/or comprehensive business plan
What are funding and philanthropic bodies looking for?
How to build an investment strategy combining different sources of funding
Dilutive vs non-dilutive - which is right for me?
When to pivot or change my capital raising strategy?
How to avoid potential pitfalls in non-dilutive funding strategy?
What are the risks in non-dilutive funding?
How to secure continuous support from funders
Key considerations in professional grant writing

Agenda:

11:30am: Registration + light lunch networking
12:10pm: Masterclass
1:25pm: Q&A & Panel Discussion
1:50pm: What's next
2:00pm: Event conclude

Meet the Experts:

Anne O'Neil
Director for Enterprise, International Partnerships and Clinical Trials at the Office for Health and Medical Research

Anne has over 25 years’ experience in the health, medical research and policy sectors. She is responsible for leading the development and implementation of major policies and programs to enhance medical research capacity in NSW, and raise the profile of NSW research and development nationally and internationally. She is responsible for the NSW Medical Device Fund and NSW Commercialisation Training Program – both have been critical to accelerating the development of NSW intellectual property and the next generation of innovators and entrepreneurs in NSW. She holds a Bachelor of Science (Physiology and Pharmacology) (Hons) and an Executive Masters of Public Administration.

Dr. Jeremy Kwarcinski

Co-Founder & CEO (iiShield) Biomedical Engineer

Dr Jeremy Kwarcinski is the co-founder of iiShield, a medical device developer and innovator for the signature KidneyPJ - a single-use, cost-effective medical device that aims to increase the available time for kidney transplantation. iiShield is one of only three companies to receive funding in 2021 from the NSW Health Medical Devices Fund. Jeremy is a current resident at the Cicada HealthTech Hub as he and his team continues to develop and refine their product in collaboration with the clinicians and surgeons across the Westmead Health Precinct, in hopes to provide a surgical environment which fosters improved short & long term transplant outcomes.

Megan O'Connor

Managing Director at Kantara Consulting

Megan O’Connor, PhD, MBA is the founder of Kantara Consulting, a boutique consultancy firm specialising in helping life science companies grow through accessing funding, government relations, and industry engagement. Before founding Kantara Consulting, Megan spent over a decade at global consulting firms and served as the National Life Science Leader of the Global Investment and Innovation Incentive team for government funding at Deloitte. Megan has also worked in an Australian biotech start-up and holds a PhD in Neurobiology. At Kantara Consulting, Megan works with Australia’s most innovative and successful companies. Kantara clients frequently appear on Australia’s Top 100 Innovators list and include recipients of the Prime Minister's Prize for Innovation and Order of Australia honourees. Megan’s clients have successfully secured funding via both State and Federal grant and investment programs.

Terry O'Riordan

Regional Manager Aus Industry

Terry O’Riordan is AusIndustry’s Regional Manager for Western Sydney. AusIndustry is the outreach arm of the Department of Industry, Science and Resources; working with business to navigate government programs while providing up to date information and industry connections. Terry has over 30 years’ experience in consulting and management with a focus on innovation, continuous improvement, digital technology, and Advanced Manufacturing.

This panel will be facilitated by Dr Duncan Macinnis

Dr Duncan Macinnis has spent more than 15 years working at the intersection of business and science, having worked in industry, tech transfer and the not-for-profit sector. Most recently, as Director for Stakeholder Engagement at MTPConnect, Duncan was an assessor on multiple grants programs (including writing the funding guidelines and application form for the Clinical Translation and Commercialisation - Medtech program), and has assisted hundreds of companies and researchers with advice and guidance in non-dilutive funding strategies.

-----------

Don't miss this opportunity to gain valuable insights from industry experts and network with fellow health tech innovators.

Register now to secure your spot in this must-attend masterclass for health tech entrepreneurs looking to amplify their presence in the market!

Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses are to help bridge the gap between research and commercialisation.

Find out more about the Cicada HealthTech Hub

The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.

Contact the host of How To Fund Your MedTech: Non-Dilutive Funding Options. A HealthTech Hub Masterclass.